Pfizer to raise $31 billion for Seagen deal in debt offering
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019.Brendan McDermid | ReutersPfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to a new filing with the Securities and Exchange Commission.Pfizer expects to complete the $43 billion Seagen buyout later this year or in early 2024. The debt offering is expected to close on May 19, according to a…